Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial. - Wikidata - awgldk - TriplyDB

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

http://www.wikidata.org/entity/Q33903205

about

Albumin dialysis improves hepatic encephalopathy and decreases circulating phenolic aromatic amino acids in patients with alcoholic hepatitis and severe liver failure Artificial and bioartificial support systems for liver failure Clinical application of bioartificial liver support systems Economic evaluation of the artificial liver support system MARS in patients with acute-on-chronic liver failure Hepatorenal syndrome The 21st International Symposium on Intensive Care and Emergency Medicine, Brussels, Belgium, 20-23 March 2001 Equipment review: the molecular adsorbents recirculating system (MARS)Meta-analysis of survival with the molecular adsorbent recirculating system for liver failure Survival Benefits With Artificial Liver Support System for Acute-on-Chronic Liver Failure: A Time Series-Based Meta-Analysis Hepatorenal syndrome: Update on diagnosis and treatment Renal failure in cirrhosis: Emerging concepts Clinical review: use of renal replacement therapies in special groups of ICU patients Albumin for end-stage liver disease Treatment and management of ascites and hepatorenal syndrome: an update Effect of the molecular adsorbent recirculating system and Prometheus devices on systemic haemodynamics and vasoactive agents in patients with acute-on-chronic alcoholic liver failure Outcomes of liver transplantation in patients with hepatorenal syndrome Artificial and bioartificial liver support Protecting the Kidney in Liver Transplant Candidates: Practice-Based Recommendations From the American Society of Transplantation Liver and Intestine Community of Practice.Life-threatening intoxication with methylene bis(thiocyanate): clinical picture and pitfalls. A case report Thromboelastography to monitor clotting/bleeding complications in patients treated with the molecular adsorbent recirculating system Molecular adsorbent recirculating system (MARS) in acute liver injury and graft dysfunction: Results from a case-control study Cost-utility of molecular adsorbent recirculating system treatment in acute liver failure.Personal view: current role of artificial liver support devices.Albumin dialysis: single pass vs. recirculation (MARS).Application of MARS artificial liver support as bridging therapy before split liver retransplantation in a 15-month-old child.Prometheus versus molecular adsorbents recirculating system: comparison of efficiency in two different liver detoxification devices.Therapy insight: Management of hepatorenal syndrome.Pathophysiology of renal disease associated with liver disorders: implications for liver transplantation. Part I.Identification of patients best suited for combined liver-kidney transplantation: part II.Evaluation of the Hepa Wash® treatment in pigs with acute liver failure.Hepatorenal syndrome in patients with cirrhosis.The pathophysiological basis of acute-on-chronic liver failure.Artificial and bioartificial support systems for liver failure: a Cochrane Hepato-Biliary Group Protocol.Molecular adsorbent recirculating system and hemostasis in patients at high risk of bleeding: an observational study.Hepatorenal syndrome: aetiology, diagnosis, and treatment.Managing liver failure.Renal dysfunction in cirrhosis.Prospects for extracorporeal liver support.Advances in critical care hepatology.Liver transplantation for Wilson disease.

P2860

Q21195009-B36380B7-304C-42B9-A32B-44508083623A Q24247462-F9ADB985-F014-4186-A89E-22EB27F1800A Q24540124-2BD2A564-E5AA-4DCE-929D-7A5BFEC7F904 Q24676081-EB3CDEDB-D076-4862-8E24-FB06C102C8B6 Q24682192-132C231F-519E-4375-A902-DA41DDA8D577 Q24796106-41D975DE-1018-401F-81FE-29041B925B66 Q24801094-697C586A-9143-446E-A58A-90297F551F2D Q26771851-E7A33CAE-757B-4879-B297-585ED8CE577C Q26773433-34AAE2BF-1FF3-418A-8B42-DD1539095409 Q26777608-89BA2704-8AA7-4BED-8DB3-1CC41D7C56BD Q26785971-27E20620-E14B-4202-B1B1-D31E179F7442 Q26853350-F2E1FE53-6DCD-40AC-A61C-DE1F8B3A6DF7 Q26999804-C0ED036F-678B-41F2-A8D8-D28EA6329AFE Q27000268-044597F8-40B8-425B-9643-CBD65B9460FF Q27499349-0D5F5759-6861-44BA-897E-1734A587D8FF Q28068506-719CA2B5-A20C-42A6-9AD5-D698282C59F9 Q28237883-176B8E12-D07C-4E69-900E-07EFF5F1265B Q30251763-B7BD1E0E-7897-450D-840F-8F019020B862 Q33239633-B26BC6FB-93F7-47B5-86EB-97433AB410A4 Q33395093-B2963192-EC3C-4E8D-9B6C-B88D08C77831 Q33558782-4158DA5A-1BA3-4211-8EA6-446D77BC0F7F Q33844163-438716C4-902B-4D9A-9109-8012BF64A3A8 Q33995791-3E19BE50-2222-444F-A29B-4DF31237DEC5 Q34148606-56E18081-5222-4275-8146-71637B600A66 Q34149700-FF96C23D-9781-431D-A8DE-3CF8466BAF79 Q34518397-04AD637A-CBF9-4C8A-BCA4-038856D76A19 Q34533221-8A33CB1D-E10B-4A5A-A664-62561DF2E8B7 Q34542843-2DA76225-EE18-4173-AFC5-C8CD079B1800 Q34575149-6D54BF8F-C6DB-4221-BBE7-DB5A5373554C Q34719069-247986DE-D341-4733-819C-428C6ED9F0AB Q34744285-1CE35402-0AE8-4740-B8F5-01EAE795FB6A Q34830328-29315F9D-6169-4FB4-BC25-D09C3838AAB1 Q34975989-AFA8A459-A355-44C2-9C9C-90F6C394DDD7 Q34999188-1900F29E-D1F2-400A-AAC7-8374597259EF Q35012890-98C40883-9B0F-4E52-B596-A1D24C92AD12 Q35032212-9ED0EF2B-4D6D-4A17-8B2F-0791BBFF02EA Q35559713-6B34B228-EFDE-4E56-90E2-1975F2CBBC7D Q35596562-D36310D2-2245-421D-8190-FC9330B7A967 Q35605215-C82E49C4-E36E-4056-B875-55C087D33971 Q35736533-11A4BC7E-22E7-4CB0-BE68-382663F43F39

P2860

Improvement of hepatorenal syndrome with extracorporeal albumin dialysis MARS: results of a prospective, randomized, controlled clinical trial.

http://www.wikidata.org/entity/Q33903205

description

2000 nî lūn-bûn

@nan

2000 թուականի Մայիսին հրատարակուած գիտական յօդուած

@hyw

2000 թվականի մայիսին հրատարակված գիտական հոդված

@hy

2000年の論文

@ja

2000年論文

@yue

2000年論文

@zh-hant

2000年論文

@zh-hk

2000年論文

@zh-mo

2000年論文

@zh-tw

2000年论文

@wuu

name

Improvement of hepatorenal syn ...... ed, controlled clinical trial.

@ast

Improvement of hepatorenal syn ...... ed, controlled clinical trial.

@en

type

label

Improvement of hepatorenal syn ...... ed, controlled clinical trial.

@ast

Improvement of hepatorenal syn ...... ed, controlled clinical trial.

@en

prefLabel

Improvement of hepatorenal syn ...... ed, controlled clinical trial.

@ast

Improvement of hepatorenal syn ...... ed, controlled clinical trial.

@en

P1433

Q33903205-9B075F05-2810-4D34-B64F-7D8AB5094475

P1476

Q33903205-462A054E-DB5F-44D7-89F3-1F423D95FD2F

P2093

Q33903205-13295F56-4901-473E-914A-BCE022C395D0

Q33903205-144DDD49-48D8-4830-B858-70E02A5FE8D6

Q33903205-6A73CFE1-1A28-4CC2-B087-D689FF39B1CA

Q33903205-6EAD0B7E-84C5-46E3-B7AD-1FC51607E610

Q33903205-764BB462-F036-4920-81AE-3EDE7E19B450

Q33903205-7894D516-AC94-4874-AEF1-74C4605E4459

Q33903205-7C027C60-A207-4010-9A32-9C75DD08CA3B

Q33903205-8A064468-44D9-429A-9536-33B1A00910B0

Q33903205-A0A0BDD0-4C35-4668-B0BD-7DA683C015E3

Q33903205-AA493FFE-3E8D-4E0E-870F-5B4679124AB6

P304

Q33903205-FDB0E8A1-9DC2-4E5C-A63A-57B28C356B02

P31

Q33903205-528F92FE-4AE4-4560-BCA7-A8059635830A

P356

Q33903205-FD571011-17C3-491A-B06B-44BC45D23502

P433

Q33903205-ED71B470-3F7E-4BFD-825F-645F344BDB6B

P478

Q33903205-D6F605E9-47E7-4858-8DE2-1701C006B76F

P577

Q33903205-62F6A95F-CCDC-43A2-8F59-07AA2CCCB115

P698

Q33903205-8B837187-B174-4577-A44D-DDCD1E96E556

P921

Q33903205-F23EA19D-B5FE-4306-9A4E-E9ECCAF23F56

P356

P1433

Liver Transplantation

P1476

Improvement of hepatorenal syn ...... ed, controlled clinical trial.

@en

P2093

Bader BD

http://www.w3.org/2001/XMLSchema#string

Berger ED

http://www.w3.org/2001/XMLSchema#string

Emmrich J

http://www.w3.org/2001/XMLSchema#string

Erley CM

http://www.w3.org/2001/XMLSchema#string

Freytag J

http://www.w3.org/2001/XMLSchema#string

Hickstein H

http://www.w3.org/2001/XMLSchema#string

Klammt S

http://www.w3.org/2001/XMLSchema#string

Korten G

http://www.w3.org/2001/XMLSchema#string

Lauchart W

http://www.w3.org/2001/XMLSchema#string

Liebe S

http://www.w3.org/2001/XMLSchema#string

P304

277-286

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1053/LV.2000.6355

http://www.w3.org/2001/XMLSchema#string

P433

3

http://www.w3.org/2001/XMLSchema#string

P478

6

http://www.w3.org/2001/XMLSchema#string

P577

2000-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

10827226

http://www.w3.org/2001/XMLSchema#string

P921